Skandinaviska Enskilda Banken Ab (Publ) Merck & Co., Inc. Transaction History
Skandinaviska Enskilda Banken Ab (Publ)
- $24.3 Billion
- Q3 2025
A detailed history of Skandinaviska Enskilda Banken Ab (Publ) transactions in Merck & Co., Inc. stock. As of the latest transaction made, Skandinaviska Enskilda Banken Ab (Publ) holds 1,730,472 shares of MRK stock, worth $161 Million. This represents 0.6% of its overall portfolio holdings.
Number of Shares
1,730,472
Previous 1,827,741
5.32%
Holding current value
$161 Million
Previous $145 Million
0.38%
% of portfolio
0.6%
Previous 0.65%
Shares
34 transactions
Others Institutions Holding MRK
# of Institutions
3,877Shares Held
1.9BCall Options Held
31.1MPut Options Held
28.5M-
Vanguard Group Inc Valley Forge, PA252MShares$23.4 Billion0.33% of portfolio
-
Black Rock Inc. New York, NY207MShares$19.2 Billion0.59% of portfolio
-
State Street Corp Boston, MA118MShares$11 Billion0.35% of portfolio
-
Wellington Management Group LLP Boston, MA75.3MShares$6.99 Billion1.16% of portfolio
-
Geode Capital Management, LLC Boston, MA59.8MShares$5.55 Billion0.33% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $235B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...